EFTA Document EFTA01481073

Date

Unknown

Source

DOJ Data Set 10

Reference

efta-efta01481073

Pages

Persons

Integrity

Loading PDF viewer...

Summary

Download Original PDF Save PDF

Ask AI About This Document

0upvotesShare

Post Reddit

Save Post Watch

Extracted Text (OCR)

EFTA Disclosure

Text extracted via OCR from the original document. May contain errors from the scanning process.

Officers, Directors: JEFFREY E EPSTEIN P/D 358 EL BRILLO WAY PALM BEACH, FL 33480 AMANDA J ELLISON SECRETARY History: File Date: 10/23/1998 Type: VOLUNTARY DISSOLUTION File Date: 4/21/1995 Type: AMENDMENT AND NAME CHANGE Comments: Name Changed To: GHISLAINE CORP. 22 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00003332 SDNY_GM_00272530 EFTA01481073

Related Documents (6)

DOJ Data Set 10OtherUnknown

EFTA01682184

186p

DOJ Data Set 10OtherUnknown

EFTA01370863

Dept. of JusticeOtherUnknown

Medical Record/Clinical Encounter: DOJ-OGR-00026334

This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.

DOJ Data Set 8CorrespondenceUnknown

EFTA00014087

DOJ Data Set 11OtherUnknown

EFTA02367961

DOJ Data Set 10OtherUnknown

EFTA01977826

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Donate More ways to support →

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.